Split History
ETFs Holding CERU »    CERU Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Cerulean Pharma is a clinical-stage, oncology-focused company applying its proprietary Dynamic Tumor Targeting™ Platform to develop various therapies. Co.'s platform is designed to create nanoparticle-drug conjugates, which consist of anti-cancer therapeutics, or payloads, covalently linked to a proprietary polymer. Co.'s principal clinical candidate, CRLX101, is in Phase 2 clinical development in patients with renal cell carcinoma and in Phase 2 and Phase 1b clinical development in patients with ovarian cancer in combination with Avastin® (bevacizumab) and paclitaxel, respectively. Co.'s second clinical candidate, CRLX301, is in Phase 1/2a clinical development. According to our CERU split history records, CERU has had 1 split.
CERU split history picture
CERU (CERU) has 1 split in our CERU split history database. The split for CERU took place on July 20, 2017. This was a 1 for 10 reverse split, meaning for each 10 shares of CERU owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.

When a company such as CERU conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the CERU split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into CERU shares, starting with a $10,000 purchase of CERU, presented on a split-history-adjusted basis factoring in the complete CERU split history. CERU split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/10/2014
End date: 07/20/2017
Start price/share: $68.50
End price/share: $6.56
Dividends collected/share: $0.00
Total return: -90.42%
Average Annual Total Return: -51.10%
Starting investment: $10,000.00
Ending investment: $957.42
Years: 3.28
Date Ratio
07/20/20171 for 10
CERU is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

CGC Split History
CGNT Split History
CHDX Split History
CHE Split History
CHFS Split History
CHRS Split History
CLBS Split History
CLDN Split History
CLDX Split History
CLRB Split History

Amedica Corporation (AMDA)
Patrick Industries, Inc. (PATK)
Whiting Petroleum Corporation (WLL)
SPI Energy Co., Ltd. (SPI)
CytRx Corporation (CYTR)
Marathon Patent Group, Inc. (MARA)
WisdomTree U.S. Total Earnings Fund (EXT)
WisdomTree U.S. Earnings 500 Fund (EPS)
WisdomTree U.S. SmallCap Dividend Fund (DES)
WisdomTree U.S. MidCap Dividend Fund (DON)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

CERU Insider Buying

CERU Split History | www.SplitHistory.com | Copyright © 2013 - 2017, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.